| Endocrine regulation of energy metabolism by the skeleton NK Lee, H Sowa, E Hinoi, M Ferron, JD Ahn, C Confavreux, R Dacquin, ... Cell 130 (3), 456-469, 2007 | 3098 | 2007 |
| A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure VK Yadav, F Oury, N Suda, ZW Liu, XB Gao, C Confavreux, ... Cell 138 (5), 976-989, 2009 | 737 | 2009 |
| Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis F Oury, M Ferron, W Huizhen, C Confavreux, L Xu, J Lacombe, P Srinivas, ... The Journal of clinical investigation 123 (6), 2421-2433, 2013 | 290 | 2013 |
| A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms CB Confavreux, RL Levine, G Karsenty Molecular and cellular endocrinology 310 (1-2), 21-29, 2009 | 276 | 2009 |
| Bone metastasis: Mechanisms, therapies, and biomarkers P Clézardin, R Coleman, M Puppo, P Ottewell, E Bonnelye, F Paycha, ... Physiological reviews 101 (3), 797-855, 2021 | 192 | 2021 |
| Sarcomas and malignant phyllodes tumours of the breast–a retrospective study C Confavreux, A Lurkin, N Mitton, R Blondet, C Saba, D Ranchère, ... European journal of cancer 42 (16), 2715-2721, 2006 | 175 | 2006 |
| Osteoporosis and mortality A Leboime, CB Confavreux, N Mehsen, J Paccou, C David, C Roux Joint Bone Spine 77, S107-S112, 2010 | 173 | 2010 |
| Novel biological markers of bone: from bone metabolism to bone physiology RD Chapurlat, CB Confavreux Rheumatology 55 (10), 1714-1725, 2016 | 154 | 2016 |
| Bone: from a reservoir of minerals to a regulator of energy metabolism CB Confavreux Kidney international 79, S14-S19, 2011 | 144 | 2011 |
| Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates CB Confavreux, A Fontana, JP Guastalla, F Munoz, J Brun, PD Delmas Bone 41 (3), 346-352, 2007 | 136 | 2007 |
| Vhl deletion in osteoblasts boosts cellular glycolysis and improves global glucose metabolism N Dirckx, RJ Tower, EM Mercken, R Vangoitsenhoven, C Moreau-Triby, ... The Journal of clinical investigation 128 (3), 1087-1105, 2018 | 80 | 2018 |
| Higher serum osteocalcin is associated with lower abdominal aortic calcification progression and longer 10-year survival in elderly men of the MINOS cohort CB Confavreux, P Szulc, R Casey, S Boutroy, A Varennes, N Vilayphiou, ... The Journal of Clinical Endocrinology & Metabolism 98 (3), 1084-1092, 2013 | 78 | 2013 |
| Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients? S Pelletier, CB Confavreux, J Haesebaert, F Guebre-Egziabher, ... Osteoporosis International 26, 2165-2174, 2015 | 71 | 2015 |
| Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors G Marcucci, G Beltrami, A Tamburini, JJ Body, CB Confavreux, P Hadji, ... Annals of Oncology 30 (6), 908-920, 2019 | 69 | 2019 |
| Lipocalin-2 counteracts metabolic dysregulation in obesity and diabetes I Mosialou, S Shikhel, N Luo, PI Petropoulou, K Panitsas, B Bisikirska, ... Journal of Experimental Medicine 217 (10), e20191261, 2020 | 68 | 2020 |
| Serum sclerostin increases after acute physical activity ME Pickering, M Simon, E Sornay-Rendu, K Chikh, MC Carlier, AL Raby, ... Calcified tissue international 101, 170-173, 2017 | 51 | 2017 |
| Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis CB Confavreux, RD Chapurlat Osteoporosis international 22, 1023-1036, 2011 | 51 | 2011 |
| Persistence at 1 year of oral antiosteoporotic drugs: a prospective study in a comprehensive health insurance database CB Confavreux, F Canoui-Poitrine, AM Schott, V Ambrosi, V Tainturier, ... European journal of endocrinology 166 (4), 735-741, 2012 | 50 | 2012 |
| Mutational profiling of bone metastases from lung adenocarcinoma: results of a prospective study (POUMOS-TEC) CB Confavreux, N Girard, JB Pialat, PP Bringuier, ... BoneKEy reports 3, 2014 | 48 | 2014 |
| Severity of osteoporosis: what is the impact of co-morbidities? C David, CB Confavreux, N Mehsen, J Paccou, A Leboime, E Legrand Joint Bone Spine 77, S103-S106, 2010 | 48 | 2010 |
